World Journal of
Pharmaceutical and Life Sciences

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Life Sciences
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
World Journal of Pharmaceutical and Life Sciences (WJPLS) has indexed with various reputed international bodies like : Google Scholar, Index Copernicus, Scientific Indexing Services (SIS), Indian citation Index (ICI), Directory of Research Journals Indexing, Scintific journal impact factorScientific Journal Impact Factor (SJIF), Jour Informatics (Under Process), UDLedge Science Citation Index, Global Impact Factor (In Process), International Impact Factor Services, International Society for Research Activity (ISRA) Journal Impact Factor (JIF), Science Library Index, Dubai, United Arab Emirates, International Innovative Journal Impact Factor (IIJIF), Scientific Journal Impact Factor (SJIF), Eurasian Scientific Journal Index (ESJI), Cosmos Impact Factor, IFSIJ Measure of Journal Quality, International Scientific Indexing, UAE (ISI), Web of Science Group (Under Process), Research Bible, Fuchu, Tokyo. JAPAN, Scholar Article Journal Index (SAJI), Scope Database, Academia, 



Hussein Jebur Abed* and Abbas Mahdi Rahmah


Background: Acromegaly is a chronic illness in the setting of excessive levels of GH and IGF-1 leading to coarse
physical features and requires assessment for surgical and non-surgical management with management of
associated comorbidities. the disease features and chronicity have negative influences on quality of life from
psychiatric point of view in addition to biochemical aspects. Aim of study: To assess the rate of depression and
anxiety in acromegaly patients with correlation to age, gender, duration of disease, hypophysectomy, Octreotide
use, deep xray therapy and response to all treatments modalities. Methods: This was a cross sectional study done
at the national diabetes center in Baghdad, Iraq. during a period of ten months from November 2020 to August included 80 known Acromegalic adults treated with either surgical or non-surgical methods or both . a
questionnaire was utilized to obtain demographic & clinical data .HAM –A scale was used to assess Anxiety while
BDI II was used to assess depression. Results: In this study, 45% of cases had mild anxiety, 16.3% had moderate
anxiety and 2.5% had severe anxiety. The prevalence of moderate to severe anxiety was significantly higher with
duration of disease > 10 years (53.8 %, p=0.015), those with abnormal GH level (52.2 %, p= 0.001) and those with
associated diabetes (52%, p=0.002). regarding depression, 36.3% of patients were in mild depression, 18.8 % were
in moderate depression And 2.5 % were in severe depression. moderate to severe depression was significantly
higher among acromegalic patients who had diabetes (40%, p=0.011), no significant association (p> 0.05) was
found between depression and other demographic and clinical characteristics. Conclusion: Longer duration of
Acromegaly and failure of GH suppression down to the previously specified target increases the chance of anxiety
in Acromegaly patients. Coexistent diabetes mellitus increases the chance of depression in addition to its impact on

[Full Text Article]   [Download Certificate]


  All Since 2019
 Citation  422  322
 h-index  9  7
 i10-index  4  2



    A PHP Error was encountered

    Severity: Notice

    Message: Undefined variable: news

    Filename: views/right_panel.php

    Line Number: 79

    A PHP Error was encountered

    Severity: Warning

    Message: Invalid argument supplied for foreach()

    Filename: views/right_panel.php

    Line Number: 79


World Journal of Pharmaceutical and life sciences Will give best paper award in every issue in the from of money along with certificate to promote research .

Best Article of current issue

Download Article : Click here